Merck shareholders re-elect all 13 directors, approve executive pay at annual meeting

Filed May 28, 2026 · Period ending May 26, 2026 · ~1 min read

Key Changes

• low

  All 13 director nominees elected to Merck's board with strong support, votes ranging from 1.6 to 1.8 billion shares in favor; Patricia Russo received lowest support at 88% approval.

  Item 5.07 verify on EDGAR →
• low

  Executive compensation approved in non-binding say-on-pay vote with 94% shareholder support (1.73 billion for vs. 109 million against), indicating satisfaction with pay practices.

  Item 5.07 verify on EDGAR →
• low

  Independent auditor appointment ratified for 2026 with 94% approval, confirming continuity in external audit relationships.

  Item 5.07 verify on EDGAR →